Arcutis Biotherapeutics said the U.S. Food and Drug Administration has accepted its application seeking expanded approval of its Zoryve topical treatment for infants with atopic dermatitis, the most ...
FDA has set a Prescription Drug User Fee Act (PDUFA) target action date of February 23, 2027Application supported by positive results from Phase 2 open-label INTEGUMENT-INFANT study and Phase 1 open-l ...
FDA has set a Prescription Drug User Fee Act (PDUFA) target action date of February 23, 2027Application supported by positive results from Phase ...
Monsoon haircare is something that’s always talked about, but while everyone’s telling us what to do and what not to do, not ...
From what supplements to consider using to how humidity may affect you, a dermatology experts explains everything you need to know to protect your skin this summer.
People have been oiling their hair for centuries as part of beauty rituals all over the world, as it is associated with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results